Ziegler Paul D
Cardiac Rhythm Disease Management Division, Medtronic Inc., Mounds View, Minnesota 55112.
J Atr Fibrillation. 2013 Feb 12;5(5):738. doi: 10.4022/jafib.738. eCollection 2013 Feb-Mar.
It is well established that the presence of atrial fibrillation (AF) is associated with an increased risk of stroke; however, the precise role that AF plays in increasing this risk is less well understood. In particular, it is not fully known whether a temporal relationship between AF and stroke exists. Early clinical trials in this field were limited by their rudimentary tools for monitoring of AF recurrences. More recently, studies employing implantable cardiac rhythm devices have brought greater precision to our ability to accurately detect and quantify episodes of AF but have been restricted to patient populations with clinical indications for those types of devices.In the future, new monitoring modalities such as subcutaneous devices and external patches may allow us to extend precise arrhythmia monitoring to the broader AF population. Due to the relatively low rate of clinical events, large clinical trials or registries will be required to fully appreciate the temporal aspects of AF and stroke and alternative metrics for quantifying AF recurrences need to be explored.
众所周知,心房颤动(AF)的存在与中风风险增加相关;然而,AF在增加这种风险中所起的确切作用却鲜为人知。特别是,AF与中风之间是否存在时间关系尚不完全清楚。该领域早期的临床试验受到监测AF复发的原始工具的限制。最近,使用植入式心律装置的研究使我们能够更精确地准确检测和量化AF发作,但仅限于有这些类型装置临床指征的患者群体。未来,诸如皮下装置和外部贴片等新的监测方式可能使我们能够将精确的心律失常监测扩展到更广泛的AF人群。由于临床事件发生率相对较低,需要进行大型临床试验或登记研究以充分了解AF和中风的时间方面,并且需要探索用于量化AF复发的替代指标。